Literature DB >> 16738314

The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis.

Takashi Yano1, Kosei Ito, Hiroshi Fukamachi, Xin-Zi Chi, Hee-Jun Wee, Ken-ichi Inoue, Hiroshi Ida, Philippe Bouillet, Andreas Strasser, Suk-Chul Bae, Yoshiaki Ito.   

Abstract

Genes involved in the transforming growth factor beta (TGF-beta) signaling pathway are frequently altered in several types of cancers, and a gastric tumor suppressor RUNX3 appears to be an integral component of this pathway. We reported previously that apoptosis is notably reduced in Runx3-/- gastric epithelial cells. In the present study, we show that a proapoptotic gene Bim was transcriptionally activated by RUNX3 in the gastric cancer cell lines SNU16 and SNU719 treated with TGF-beta. The human Bim promoter contains RUNX sites, which are required for its activation. Furthermore, a dominant negative form of RUNX3 comprised of amino acids 1 to 187 increased tumorigenicity of SNU16 by inhibiting Bim expression. In Runx3-/- mouse gastric epithelium, Bim was down-regulated, and apoptosis was reduced to the same extent as that in Bim-/- gastric epithelium. We confirmed comparable expression of TGF-beta1 and TGF-beta receptors between wild-type and Runx3-/- gastric epithelia and reduction of Bim in TGF-beta1-/- stomach. These results demonstrate that RUNX3 is responsible for transcriptional up-regulation of Bim in TGF-beta-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16738314      PMCID: PMC1489128          DOI: 10.1128/MCB.01926-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Polycystic kidney disease prevented by transgenic RNA interference.

Authors:  P Bouillet; M Robati; M Bath; A Strasser
Journal:  Cell Death Differ       Date:  2005-07       Impact factor: 15.828

2.  RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.

Authors:  Xin-Zi Chi; Jeung-Ook Yang; Kwang-Youl Lee; Kosei Ito; Chohei Sakakura; Qing-Lin Li; Hye-Ryun Kim; Eun-Jeung Cha; Yong-Hee Lee; Atsushi Kaneda; Toshikazu Ushijima; Wun-Jae Kim; Yoshiaki Ito; Suk-Chul Bae
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

3.  Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy.

Authors:  Ting-Ting Tan; Kurt Degenhardt; Deirdre A Nelson; Brian Beaudoin; Wilberto Nieves-Neira; Philippe Bouillet; Andreas Villunger; Jerry M Adams; Eileen White
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

4.  Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis.

Authors:  Daoyan Wei; Weida Gong; Sang C Oh; Qiang Li; Won Dong Kim; Liwei Wang; Xiangdong Le; James Yao; Tsung T Wu; Suyun Huang; Keping Xie
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

5.  Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells.

Authors:  I Tachibana; M Imoto; P N Adjei; G J Gores; M Subramaniam; T C Spelsberg; R Urrutia
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

6.  Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis.

Authors:  Sofia Edlund; So Young Lee; Susanne Grimsby; Shouthing Zhang; Pontus Aspenström; Carl-Henrik Heldin; Maréne Landström
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

7.  Causal relationship between the loss of RUNX3 expression and gastric cancer.

Authors:  Qing Lin Li; Kosei Ito; Chohei Sakakura; Hiroshi Fukamachi; Ken ichi Inoue; Xin Zi Chi; Kwang Youl Lee; Shintaro Nomura; Chang Woo Lee; Sang Bae Han; Hwan Mook Kim; Wun Jae Kim; Hiromitsu Yamamoto; Namiko Yamashita; Takashi Yano; Toshio Ikeda; Shigeyoshi Itohara; Johji Inazawa; Tatsuo Abe; Akeo Hagiwara; Hisakazu Yamagishi; Asako Ooe; Atsushi Kaneda; Takashi Sugimura; Toshikazu Ushijima; Suk Chul Bae; Yoshiaki Ito
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

8.  Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.

Authors:  Hiroyuki Tagawa; Sivasundaram Karnan; Ritsuro Suzuki; Keitaro Matsuo; Xiaohua Zhang; Akinobu Ota; Yasuo Morishima; Shigeo Nakamura; Masao Seto
Journal:  Oncogene       Date:  2005-02-17       Impact factor: 9.867

9.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

10.  Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.

Authors:  P Franzén; P ten Dijke; H Ichijo; H Yamashita; P Schulz; C H Heldin; K Miyazono
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  65 in total

1.  RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.

Authors:  Mohd Feroz Mohd Omar; Kosei Ito; Min En Nga; Ross Soo; Bee Keow Peh; Tuty Muliana Ismail; Bhavin Thakkar; Richie Soong; Yoshiaki Ito; Manuel Salto-Tellez
Journal:  Pathol Oncol Res       Date:  2012-06-24       Impact factor: 3.201

2.  The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes.

Authors:  Shannon M Ruppert; Wenqing Li; Ge Zhang; Adina L Carlson; Arati Limaye; Scott K Durum; Annette R Khaled
Journal:  Biochim Biophys Acta       Date:  2012-06-21

3.  Tumor suppressor function of RUNX3 in breast cancer.

Authors:  Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

4.  RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.

Authors:  Chizu Yamada; Toshinori Ozaki; Kiyohiro Ando; Yusuke Suenaga; Ken-ichi Inoue; Yoshiaki Ito; Rintaro Okoshi; Hajime Kageyama; Hideki Kimura; Masaru Miyazaki; Akira Nakagawara
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

5.  Identification of RUNX3 as a component of the MST/Hpo signaling pathway.

Authors:  Boram Min; Min-Kyu Kim; Joo-Won Zhang; Jiyeon Kim; Kwang-Chul Chung; Byung-Chul Oh; Gary S Stein; Yong-Hee Lee; Andre J van Wijnen; Suk-Chul Bae
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

Review 6.  New insights into the inactivation of gastric tumor suppressor RUNX3: the role of H. pylori infection.

Authors:  Ying-Hung Nicole Tsang; Acacia Lamb; Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2011-02       Impact factor: 4.429

7.  Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation.

Authors:  Y H Tsang; A Lamb; J Romero-Gallo; B Huang; K Ito; R M Peek; Y Ito; L F Chen
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

8.  Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer.

Authors:  Ming Wang; Chenglong Li; Beiqin Yu; Liping Su; Jianfang Li; Jingfang Ju; Yingyan Yu; Qinlong Gu; Zhenggang Zhu; Bingya Liu
Journal:  J Gastroenterol       Date:  2013-01-22       Impact factor: 7.527

9.  Runx3 expression in lymph nodes with metastasis is associated with the outcome of gastric cancer patients.

Authors:  Hong-Wei Xu; Feng Ren; Yan-Ming Yu; Cheng-Zhong Cai
Journal:  Oncol Lett       Date:  2011-08-11       Impact factor: 2.967

10.  Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells.

Authors:  Gary M Wildey; Philip H Howe
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.